| Pipeline |
| APS Product Pipeline |
| Therapeutic Areas |
| Selected Studies and Results |
| Proposed Mechanism of Action for AP002 |
| Technology and Intellectual Property |
| APS Product Pipeline |
|
APS product pipeline consists of a wide range of proprietary product candidates that are under development. Cumulatively, these products address significant unmet medical needs and have a market potential of over $2B. These products are based on APS proprietary peptides that have been specifically developed to provide supportive care for a variety of clinical indications including chemo/radiation induced mucositis, proctitis and inflammatory bowel disease. APS is currently partnering with pharmaceutical companies to extend the platform and also to develop new drugs for a wide range of clinical indications. These can be categorized in 3 broad areas of application:
|
 |